BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30
• 31

• Business

  Aptuit LLC Release: Company Announces Drug Discovery Collaboration With Massachusetts General Hospital To Identify Novel Treatments For Gram-Negative Infections

  January 24, 2017

   · 

  1 min read
• Vectura Release: FDA Approves IND To Support Company’s Wholly-Owned Programme VR647 In Paediatric Asthma

  January 24, 2017

   · 

  1 min read
• Isofol Medical AB Release: FDA Clears Company’s IND Application To Start Clinical Program Within Colorectal Cancer With Modufolin

  January 24, 2017

   · 

  4 min read
• Sphere Fluidics Release: Company Launches E-commerce Site Allowing Researchers Rapid Access to Specialist Microfluidic Products

  January 24, 2017

   · 

  1 min read
• Business

  ResMed Announces Results For The Second Quarter Of Fiscal Year 2017

  January 24, 2017

   · 

  5 min read
• Policy

  Mithra Pharmaceuticals Release: Company Plans To Submit Myring For US And EU Approval In Q2 2017

  January 24, 2017

   · 

  3 min read
• FDA

  Medtronic Release: Company Announces CE Mark For New Lower Profile Hawkone 6f Directional Atherectomy System

  January 24, 2017

   · 

  4 min read
• Genetown

  Aushon Biosystems Release: New U.S. Patent Allowance Granted To Company For Microarray Printing Of Complex Biological And Chemical Fluids

  January 24, 2017

   · 

  2 min read
• Genetown

  Enanta Pharmaceuticals, Inc. Release: Pharma Announces EMA Grants Accelerated Assessment, Validates Marketing Authorization Application For AbbVie’s Investigational HCV Regimen Of Glecaprevir/Pibrentasvir (G/P) For The Treatment Of All Major Genotypes (GT

  January 24, 2017

   · 

  6 min read
• Biotech Beach

  Roche Release: Company Selects Vivonoetics To Provide Advanced Respiratory Assessment For The FIREFISH Phase II Multicenter Clinical Trial In Infants With Spinal Muscular Atrophy Type 1.

  January 24, 2017

   · 

  3 min read